The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for subcutaneous use for most previously approved adult, solid tumor Opdivo (nivolumab) ...

Halozyme provides subcutaneous drug delivery solutions, with several major new products recently approved. Click here to find ...

During a Case-Based Roundtable® event, Daniel J. George, MD, discusses how often community oncology participants see patients ...

On December 20, 2024, the FDA granted accelerated approval to the combination of encorafenib (Braftovi), cetuximab (Erbitux), and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in metastatic ...

Monoclonal Antibodies IndustryThe global monoclonal antibodies (mAbs) industry, valued at USD 186 billion in 2021, is ...

CARsgen Therapeutics' claudin 18.2-targeting autologous CAR-T therapy satricabtagene autoleucel (satri-cel) has shown efficacy in gastric cancer, in a rare win for this type of cell therapy in a solid ...

Bristol-Myers Squibb (NYSE:BMY – Get Free Report) was the target of unusually large options trading activity on Thursday. Stock investors acquired 296,826 call options on the company. This is an ...

1. Opdivo – immuno-oncology's trailblazer Bristol-Myers Squibb's (BMS) immunotherapy Opdivo was undoubtedly the drug to watch in 2015, its promise of pushing the boundaries for cancer treatment ...

By narrowing their research to overweight and obese individuals, Roswell Park researchers found that metformin might offer ...

Jason Peña, now 14, was shot in the head on a highway in the state of Durango, a family spokeswoman said. His father and uncle, both U.S. citizens, and a Mexican relative were also killed. By ...

The raging bushfire has burnt through land the size of Singapore. But one tiny glimmer of hope was spotted from the sky. An Aussie shopper going about their business this morning claimed he came ...